<DOC>
	<DOCNO>NCT01066286</DOCNO>
	<brief_summary>Core binding factor ( CBF ) positive acute myeloid leukemia ( AML ) consist 15 % patient overall AML , expect harbor favorable prognosis . However , around half case relapse . Accordingly , sophisticated classification CBF positive AMLs essential achieve improvement treatment outcome . The current study design evaluate CBF positive AML patient genome-wide SNP array KIT mutation study CBF positive AML patient diagnose Samsung Medical Center Hwasun Chonnam National University Hospital , Korea 1994 2008 . 1 . Construction CBF positive AML patient cohort : clinical database establishment ( include treatment outcomes prognosis ) extraction/storage tumor cell DNAs marrow sample , process Affymetrix SNP array 6.0 . 2 . Construction prognostic predictive model use pharmacogenomics result genotype copy number variation ( CNVs ) . 3 . Detection hide microscopic cytogenetic lesion SNP array technique , correlation clinical outcome CBF positive AML . 4 . Detection KIT , FLT3/ITD , NPM1 gene mutation correlation clinical outcome CBF positive AML . The current study attempt analyze genetic data core binding factor ( CBF ) positive acute myeloid leukemia ( AML ) use genome wide SNP array technique tumor DNAs collect time diagnosis . 1 . To detect microcytogenetic lesion analyze prognostic significance 2 . To analyze genome-wide genotype copy number variation ( CNVs ) use pharmacogenetic approach construct prognostic predictive model 3 . To detect KIT , FLT3/ITD NPM1 mutation evaluate prognostic significance . The present study establish individualize therapy CBF positive AML , provide basis molecular marker guide clinical trial CBF positive AML .</brief_summary>
	<brief_title>Genome Wide SNP Array-based Approach Detect Micro-cytogenetic Lesions KIT Mutation Improve Treatment Outcomes Patients With Core-binding Factor Positive Acute Myeloid Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>patient core bind factor positive acute myeloid leukemia 18 year old patient treat standard chemotherapy patient available medical record store bone marrow specimen time diagnosis definive criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>genome wide SNP-array</keyword>
	<keyword>micro-cytogenetic lesion</keyword>
	<keyword>KIT mutation</keyword>
	<keyword>core binding factor</keyword>
	<keyword>acute myeloid leukemia</keyword>
	<keyword>The Approval status change Pending Approved .</keyword>
</DOC>